SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following its Q3 earnings report, which beat consensus estimates, fueling optimism about the company's profitability and growth. The community is discussing the potential for a short squeeze and analysts potentially increasing price targets. Investors are analyzing the report and guidance, with some suggesting the company is poised for a significant revaluation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending due to anticipation surrounding upcoming earnings and the potential completion of the Northern Data acquisition, which could significantly expand Rumble's AI and cloud capabilities. Community discussions revolve around the high short interest and the possibility of a short squeeze, while also weighing the impact of Tether's involvement and strategic direction. Investors are closely watching for updates on profitability and key performance metrics.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com ($MNDY) is trending after an earnings report, with mixed reactions from the community. While the company beat expectations, some express concerns over Q4 sales forecasts and the potential impact of AI. Community members are actively debating the stock's future direction, with some anticipating a further decline and others seeing a buying opportunity due to the recent sell-off.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

Anavex Life Sciences ($AVXL) is trending as investors eagerly await the CHMP opinion on Blarcamesine, a potential treatment for Alzheimer's, with the decision expected soon. The community is focused on the potential for a positive opinion and the implications for partnerships and market value, while some express concern about the timing of the announcement and potential market manipulation. Discussions also highlight the drug's safety profile and potential benefits over existing treatments.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending due to a recent earnings report, which included a revenue beat but a cut to the FY25 adjusted EBITDA view. A new long-term sales agreement with Naturgy of Spain is also driving interest, with community discussion focused on the company's outlook, export capabilities, and the potential impact of EU gas storage levels.

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Cogent Biosciences Inc

COGT is trending due to positive Phase 3 trial results for bezuclastinib in gastrointestinal stromal tumors (GIST), sparking community excitement. Investors are also closely watching the new S3 filing and upcoming data releases, with some speculating on potential buyout scenarios. Community members are actively discussing price targets and data release timelines.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as community members discuss the potential for a short squeeze, highlighting high borrow fees and a locked float. Discussions center around institutional 

Brooder is an AI engine built for creators to generate their own characters and launch them as tokens on the Solana blockchain using our launchpad. Our framework combines the latest LLM capabilities, users can customise their own contract address and launch a token directly onto Pump Fun for free. Our utility token $BROOD will be the native currency of the platform with a burning mechanism for each deployment + a subscription model paid in $BROOD.

Brooder

Brooder ($BROOD) is trending as the crypto community observes its stable price action and anticipates a potential breakout. Traders are highlighting the token's 'tight structure' and 'calm movement', suggesting a coiled spring dynamic. Speculation is building around a possible surge, with some calling for immediate accumulation before the 'swarm awakens'.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending due to a recent upgrade from Deutsche Bank to a "Buy" rating, citing an attractive entry point amid the growing demand for rare earth minerals; however, some investors express concern over the company's current lack of profitability. Community members are actively discussing the analyst upgrade, potential government support, and long-term contracts as positive catalysts, while others focus on near-term catalysts, such as the upcoming return to profitability.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance ($PSKY) is trending amid speculation about a potential acquisition of Warner Bros. Discovery ($WBD), with community chatter focusing on offer details, regulatory hurdles, and potential benefits of the merger, such as cost synergies and a stronger streaming platform. Community members are also discussing AI's role in future content creation and the impact of recent executive decisions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nektar Therapeutics (NASDAQ:NKTR) Receives Average Rating of "Moderate Buy" from Analysts

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven brokerages that are covering the firm, MarketBeat.com reports. One research...

Nektar Therapeutics (NASDAQ:NKTR) Announces Earnings Results, Beats Estimates By $1.00 EPS

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.85) EPS for the quarter, beating the consensus estimate...

New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting New Data from REZOLVE-AD Study of Rezpegaldesleukin...

Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

NKTR posts a narrower Q3 loss and a revenue beat, while its rezpeg program advances with key phase IIb milestones.

Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of +35.09% and +11.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Nektar Therapeutics Reports Third Quarter 2025 Financial Results

Nektar Therapeutics Reports Third Quarter 2025 Financial Results Nektar Therapeutics Reports Third Quarter 2025 Financial Results PR Newswire SAN FRANCISCO, Nov. 6, 2025 SAN FRANCISCO, Nov. 6, 2025...

Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London PR Newswire SAN...

Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Nektar (NKTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets

Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets Nektar to Announce Financial Results for the Third Quarter on...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$58.15
Prev Close	$55.12
Open	$56.00
Dividend Yield	0.00%
50-Day Moving Average	$54.43
Beta	2.01
Avg. Volume	842,874.74
PE Ratio	-6.42

52-Week High	$66.92
52-Week Low	$6.48
Market Capitalization	$1.06B
EPS (Annual)	-$8.68
Price to Book	-28.80
Revenue Per Employee	$1.61M
Enterprise Value/EBITDA	N/A

NKTR
Nektar Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NKTR News

NKTRNektar Therapeutics